Stanford Medicine

The artificial intelligence technology can be trained by pathologists, giving them personalized assistance in identifying cells that might indicate diseases such as cancer or endometritis.

At the graduation ceremony, Minor encouraged the Class of 2024 to choose optimism in their careers: “Create the best out of any situation and be the light that leads others.”…

Speakers at the ceremony that awarded PhD, MD and master’s degrees encourage students to adopt optimism, listen to their muse and dance to their own beat.

In an analysis of more than 2 million patient records, researchers discovered that people taking angiotensin receptor blockers for high blood pressure were less likely to develop epilepsy.

Brain imaging, known as functional MRI, combined with machine learning can predict a treatment response based on one’s depression “biotype.”…

In April, the FDA warned of risk of secondary cancers in people receiving CAR-T cell therapy. A large Stanford Medicine study finds the risk is low and not related to the CAR-T cells.

Paxlovid, effective in preventing severe COVID-19, didn’t appear to help long-COVID patients in this single-center study. But further research may show benefits with different doses or for people with specific symptoms.

Professor of psychiatry and behavioral health Leanne Williams will lead a project to define depression’s cognitive biotypes and create tools for clinicians to diagnose and treat patients.

The professor of dermatology and genetics was honored with the 2024 Lurie Prize for his studies into the role of long noncoding RNA in health and disease.

New research in mice by Stanford Medicine scientists has found that the process of adaptive myelination, which helps the brain learn new skills, can also promote addiction to opioids.

In a finding that vastly expands the understanding of tumor evolution, researchers discover genetic biomarkers that can predict the breast cancer subtype a patient is likely to develop.